DSM Entering U.S. Via Catalytica: European Bulk Firms Going Global
Executive Summary
DSM plans to establish a U.S. presence for its bulk active ingredient and contract manufacturing operations through the acquisition of Catalytica Pharmaceuticals.
You may also be interested in...
Aptuit Eyes Biologics Production After Buying Clinical Trial Material Suppliers
Aptuit plans to purchase biologics pilot manufacturing and protein development capabilities as part of the continuing expansion strategy for the drug development service provider
Aptuit Eyes Biologics Production After Buying Clinical Trial Material Suppliers
Aptuit plans to purchase biologics pilot manufacturing and protein development capabilities as part of the continuing expansion strategy for the drug development service provider
DSM Submits “Final” GMP Report To FDA; New Quality Systems In Place
DSM Pharmaceuticals is highlighting new environmental monitoring systems in its response to FDA about recent good manufacturing practices inspections